Tata 1mg revenue nears Rs 3,000 Cr in FY26; loss narrows to Rs 287 Cr

Tata 1mg's consolidated revenue grew 23% to Rs 2,936 crore in FY26 from Rs 2,392 crore in FY25.

Tata 1mg's combined net loss narrowed to Rs 287 crore in FY26, with Tata 1mg Technologies contributing a profit of Rs 23 crore.

Tata 1mg Healthcare Solutions reported revenue of Rs 2,440 crore and a loss of Rs 310 crore, while Tata 1mg Technologies added Rs 496 crore in revenue.

The platform competes with Reliance-backed Netmeds, PharmEasy, and Apollo 24/7 in the online healthcare space.

Tata Digital acquired a majority stake in 1mg in June 2021 as part of its digital ecosystem strategy.